Title: A 2 year prospective study to evaluate the onset of action of Mavenclad in subjects with highly active relapsing Multiple Sclerosis

Cardiff & Vale University Health Board

Principal Investigator
None Yet Associated

Project Details
Net value award figure for Cardiff University: £12,324.00
Start date: 17/09/2018
End date: 31/12/2020

Last updated on 2020-27-09 at 06:01